Group One Trading’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,500
| Closed | -$3.2K | – | 8219 |
|
|
2025
Q4 | $3.2K | Sell |
2,500
-4,000
| -62% | -$5.37K | ﹤0.01% | 7376 |
|
|
2025
Q3 | $8.45K | Buy |
6,500
+1,300
| +25% | +$1.7K | ﹤0.01% | 7276 |
|
|
2025
Q2 | $6.24K | Buy |
+5,200
| New | +$5.76K | ﹤0.01% | 6988 |
|
|
2024
Q4 | – | Sell |
-6,000
| Closed | -$11.6K | – | 7642 |
|
|
2024
Q3 | $11.6K | Sell |
6,000
-193,500
| -97% | -$379K | ﹤0.01% | 5534 |
|
|
2024
Q2 | $353K | Sell |
199,500
-275,400
| -58% | -$673K | ﹤0.01% | 2887 |
|
|
2024
Q1 | $1.29M | Buy |
474,900
+464,900
| +4,649% | +$1.12M | ﹤0.01% | 1868 |
|
|
2023
Q4 | $22.1K | Hold |
10,000
| – | – | ﹤0.01% | 5670 |
|
|
2023
Q3 | $29K | Buy |
10,000
+1,300
| +15% | +$3.4K | ﹤0.01% | 5576 |
|
|
2023
Q2 | $16.8K | Buy |
8,700
+1,300
| +18% | +$2.57K | ﹤0.01% | 6099 |
|
|
2023
Q1 | $14.4K | Sell |
7,400
-6,300
| -46% | -$12.4K | ﹤0.01% | 5732 |
|
|
2022
Q4 | $16K | Hold |
13,700
| – | – | ﹤0.01% | 5741 |
|
|
2022
Q3 | $15K | Sell |
13,700
-400
| -3% | -$605 | ﹤0.01% | 6256 |
|
|
2022
Q2 | $23K | Buy |
14,100
+3,700
| +36% | +$9.15K | ﹤0.01% | 6180 |
|
|
2022
Q1 | $37K | Sell |
10,400
-43,900
| -81% | -$152K | ﹤0.01% | 6333 |
|
|
2021
Q4 | $213K | Buy |
54,300
+10,300
| +23% | +$48.2K | ﹤0.01% | 5023 |
|
|
2021
Q3 | $290K | Sell |
44,000
-43,500
| -50% | -$286K | ﹤0.01% | 4784 |
|
|
2021
Q2 | $539K | Sell |
87,500
-16,300
| -16% | -$87.1K | ﹤0.01% | 4143 |
|
|
2021
Q1 | $469K | Sell |
103,800
-74,200
| -42% | -$408K | ﹤0.01% | 4110 |
|
|
2020
Q4 | $1.07M | Sell |
178,000
-151,600
| -46% | -$996K | ﹤0.01% | 2584 |
|
|
2020
Q3 | $2.45M | Buy |
329,600
+311,000
| +1,672% | +$2.15M | 0.01% | 1441 |
|
|
2020
Q2 | $75K | Buy |
18,600
+12,600
| +210% | +$43.9K | ﹤0.01% | 4110 |
|
|
2020
Q1 | $15K | Buy |
+6,000
| New | +$19.7K | ﹤0.01% | 4382 |
|
|
2019
Q4 | – | Sell |
-300
| Closed | -$1K | – | 5371 |
|
|
2019
Q3 | $1K | Sell |
300
-200
| -40% | -$1.57K | ﹤0.01% | 4986 |
|
|
2019
Q2 | $6K | Buy |
+500
| New | +$6.37K | ﹤0.01% | 4553 |
|
|
2019
Q1 | – | Sell |
-4,300
| Closed | -$37K | – | 5089 |
|
|
2018
Q4 | $37K | Buy |
+4,300
| New | +$33.5K | ﹤0.01% | 3708 |
|
|
2016
Q1 | – | Sell |
-16,300
| Closed | -$176K | – | 4759 |
|
|
2015
Q4 | $176K | Buy |
16,300
+6,300
| +63% | +$61.9K | ﹤0.01% | 2591 |
|
|
2015
Q3 | $81K | Buy |
+10,000
| New | +$157K | ﹤0.01% | 3200 |
|
|
2015
Q1 | – | Sell |
-12,500
| Closed | -$422K | – | 4974 |
|
|
2014
Q4 | $422K | Sell |
12,500
-6,000
| -32% | -$170K | 0.01% | 1679 |
|
|
2014
Q3 | $453K | Buy |
+18,500
| New | +$520K | 0.01% | 1696 |
|
|
2014
Q2 | – | Sell |
-6,500
| Closed | -$286K | – | 5336 |
|
|
2014
Q1 | $286K | Sell |
6,500
-1,000
| -13% | -$44K | ﹤0.01% | 2138 |
|
|
2013
Q4 | $287K | Sell |
7,500
-1,500
| -17% | -$44.2K | ﹤0.01% | 2112 |
|
|
2013
Q3 | $197K | Buy |
+9,000
| New | +$177K | ﹤0.01% | 2400 |
|
Other funds holding LAB
CC
MCO
LFCM
VCM
HBWM
Group One Trading's LAB Position: Q1 2026 in Review
Group One Trading reduced its Standard BioTools (LAB) stake by 99% in Q1 2026, selling an estimated $32.1K and leaving 214 shares worth $197. The position accounts for ﹤0.01% of the portfolio, ranked #7393.
Group One Trading first reported a position in LAB in Q3 2013 and has held it in 31 quarters since. The position peaked at $1.43M in Q4 2013. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.
- Group One Trading held 214 shares of Standard BioTools worth $197 as of Q1 2026.
- Group One Trading sold 26,492 Standard BioTools shares in Q1 2026, an estimated $32.1K.
- Standard BioTools made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7393 holding.
- Group One Trading first reported a position in Standard BioTools in Q3 2013 and has held it in 31 quarters since.
- Group One Trading's Standard BioTools position peaked at $1.43M in Q4 2013.
- 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.